Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07413991Not ApplicableRecruiting

Expressive Writing Program Among Young Adults With Blood Cancer

Role: lead

NCT07226609Not ApplicableRecruiting

A Dietary Study for People With Multiple Myeloma

Role: collaborator

NCT05745285Not ApplicableRecruiting

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Role: collaborator

NCT07173322Recruiting

The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey

Role: lead

NCT04794387Completed

The Lymphoma and Leukemia Society Amended COVID-19 Registry

Role: lead

NCT04806295Recruiting

The Leukemia and Lymphoma Society (LLS) National Research Registry

Role: lead

All 6 trials loaded